These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11681654)

  • 1. An advanced and detailed in vitro validation procedure for the radiolabeling of carrier-free terbutaline sulphate dry powder.
    Walker PS; Petterson GL; Bondesson E; Conway JH
    J Aerosol Med; 2001; 14(2):227-36. PubMed ID: 11681654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary clearance rate of two chemically different forms of inhaled pertechnetate.
    Walker PS; Conway JH; Fleming JS; Bondesson E; Borgström L
    J Aerosol Med; 2001; 14(2):209-15. PubMed ID: 11681652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.
    Borgström L; Bondesson E; Morén F; Trofast E; Newman SP
    Eur Respir J; 1994 Jan; 7(1):69-73. PubMed ID: 8143834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.
    Abdelrahim ME
    Respir Med; 2010 May; 104(5):682-9. PubMed ID: 20004090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.
    Derom E; Borgström L; Van Schoor J; Löfroos AB; Pauwels R
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1398-402. PubMed ID: 11704585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
    Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
    J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler.
    Newman SP; Morén F; Trofast E; Talaee N; Clarke SW
    Eur Respir J; 1989 Mar; 2(3):247-52. PubMed ID: 2731602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers.
    Flament MP; Leterme P; Gayot A
    Int J Pharm; 2004 May; 275(1-2):201-9. PubMed ID: 15081150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terbutaline as powder inhalation from Bricanyl Turbuhaler compared to terbutaline as nebulizer solution in severe chronic airways obstruction.
    Hansen NC
    Eur Respir J; 1989 Sep; 2(8):716-20. PubMed ID: 2680581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turbuhaler: a new device for dry powder terbutaline inhalation.
    Johnsen CR; Weeke ER
    Allergy; 1988 Jul; 43(5):392-5. PubMed ID: 3046409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler.
    Borgström L; Bengtsson T; Derom E; Pauwels R
    Int J Pharm; 2000 Jan; 193(2):227-30. PubMed ID: 10606786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhalation device influences lung deposition and bronchodilating effect of terbutaline.
    Borgström L; Derom E; Ståhl E; Wåhlin-Boll E; Pauwels R
    Am J Respir Crit Care Med; 1996 May; 153(5):1636-40. PubMed ID: 8630614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the generation of radiolabeled monodisperse albuterol particles using the spinning-top aerosol generator.
    Usmani OS; Biddiscombe MF; Underwood SR; Barnes PJ
    J Nucl Med; 2004 Jan; 45(1):69-73. PubMed ID: 14734675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimisation of powders for pulmonary delivery using supercritical fluid technology.
    Rehman M; Shekunov BY; York P; Lechuga-Ballesteros D; Miller DP; Tan T; Colthorpe P
    Eur J Pharm Sci; 2004 May; 22(1):1-17. PubMed ID: 15113578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro characterisation of the nebulised dose during non-invasive ventilation.
    Abdelrahim ME; Plant P; Chrystyn H
    J Pharm Pharmacol; 2010 Aug; 62(8):966-72. PubMed ID: 20663030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler).
    Persson G; Wirén JE
    Eur Respir J; 1989 Mar; 2(3):253-6. PubMed ID: 2731603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.